Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 13 | Issue 1 | pp. 43–47Open access
Age-related Variation in TSH Levels in Patients with Down’s Syndrome -A Ten Year Longitudinal Study
- 1,
- 2,
- 1,
- 3,
- 4*
- 1 Department of Anatomy, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA.
- 2 Department of Dentistry, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA.
- 3 Genetic Health and Research Centre, Nashik, Maharashtra, INDIA.
- 4 Department of Biochemistry, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Suresh Kondaveeti
Department of Biochemistry, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA.
Email: sureshbabu_kondaveeti@yahoo.com
- Received:
- Jul 31, 2022
- Accepted:
- Oct 20, 2022
- DOI:
- 10.5530/223097131714
How to cite
Ambike, M., Kazi, N., Prasad, A., Chopade, D., & Kondaveeti, S. Age-related Variation in TSH Levels in Patients with Down’s Syndrome -A Ten Year Longitudinal Study. International Journal of Pharmaceutical Investigation, 13(1), 43–47. https://doi.org/10.5530/223097131714
Abstract
Background: A well-established finding is that thyroid disease is seen more commonly in individuals suffering from Down’s Syndrome than in people without the condition. Patients are at risk from childhood to adulthood. Thyroid Stimulating Hormone (TSH) levels are essential for diagnosing and managing hypothyroidism. Thyroid dysfunction increases with age in individuals diagnosed with Down’s Syndrome, according to a study undertaken by Karlsson B et al. in 1998. Our study aims at investigating the TSH level variations over a 10-year period, in individuals affected by Down’s Syndrome, belonging to different age groups. Materials and Methods: Present study was conducted to include 40 individuals between the ages of 9 years to 27 years who were assessed at the ‘Down Syndrome Care Association, Nashik, India’. Between 2009 and 2019, annual testing of thyroid function status was conducted and TSH levels in collected samples were analyzed. Five Different age groups, (9 - 15 years, 16 - 22 years, 23 - 29 years and 30 - 36 years) were identified, and data was segregated. Statistical analysis was performed over collected data and results were drawn. Results: The TSH levels in 9-15 years ranged between 5.21 mU/L - 7.13 mU/L, in 16-22 years, it was 5.66 mU/L - 6.56 mU/L, in 23-29 years, it was 4.33 mU/L - 7.37 mU/L and in 30-36 years it was 3.62 mU/L - 9.43 mU/L. Conclusion: Variations are observed in the fluctuating TSH values in individuals with Down’s Syndrome belonging to different age groups. Periodic analysis of thyroid function is recommended highly as age increases since variations in TSH levels are seen to have a direct relation to it.
Keywords
Subject
Article metadata
| Title | Age-related Variation in TSH Levels in Patients with Down’s Syndrome -A Ten Year Longitudinal Study |
|---|---|
| Authors | Mandar Ambike; Nabilah Kazi; Arun Prasad; Dnyandeo Chopade; Suresh Kondaveeti |
| Affiliations | Department of Anatomy, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA.; Department of Dentistry, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA.; Genetic Health and Research Centre, Nashik, Maharashtra, INDIA.; Department of Biochemistry, Symbiosis Medical College for Women (Affiliated to Symbiosis International University), Pune, Maharashtra, INDIA. |
| Corresponding author | sureshbabu_kondaveeti@yahoo.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 13, Issue 1 |
Also in this issue
- A Review on Different Solubility Enhancement Techniques of Ticagrelorpp. 1–6
- Herbal Bioenhancers with Nanocarriers: A Promising Approach for Oral Peptide Deliverypp. 7–13
- Clozapine: A Scientific Analysis of Global Publications during 1970-2021pp. 14–21
- Cardioprotective and Hepatoprotective Effects of Ixora pavetta and Tecoma capensis Leaf Extractspp. 22–27
- Optimization of Green Synthesized Black Tea Nanoparticles using Central Composite Designpp. 28–36